Centessa Pharmaceuticals plc — Director's Dealing 2021

Jun 3, 2021

SEC Form 3/A — Form 3/A

Issuer: Centessa Pharmaceuticals plc (CNTA)
CIK: 0001847903
Period of Report: 2021-05-27

Reporting Person: INDEX VENTURES LIFE VI (JERSEY) L.P. (10% Owner)
Reporting Person: Yucca (Jersey) SLP (10% Owner)
Reporting Person: Index Venture Life Associates VI Ltd (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	9812368	Direct
Ordinary Shares	149421	Direct

Footnotes

F1: Represents A Ordinary Shares that will be redesignated as Ordinary Shares immediately prior to the closing of the initial public offering ("IPO").

F2: Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

F3: Held by Index Ventures Life VI (Jersey) LP, a Jersey limited partnership ("Index Ventures Life VI"). Index Venture Life Associates VI Limited, a Jersey limited liability company ("Index Venture Life VI GP"), is the managing general partner of Index Ventures Life VI. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Index Ventures Life VI, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they have beneficial ownership of such shares for Section 16 or any other purpose.

F4: Held by Yucca (Jersey) SLP, a Jersey separate limited partnership ("Yucca"). Yucca administers the Index Ventures Life VI co-investment vehicle that is contractually required to mirror the investment in the shares by Index Ventures Life VI. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Yucca, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they have beneficial ownership of such shares for Section 16 or any other purpose.